On Chemball
My Chemball
+86-571-8627 3270
Yunpeng Pharmaceutical Group Co.,Ltd.
Yunpeng Pharmaceutical Group Co.,Ltd.
26 YRS
Shanxi, China
Main Products:
Mexiletine Hydrochloride / Sulfonium, (3-Amino-3-Carboxypropyl)Dimethyl-, Chloride / Indometacin / S-Carboxymethyl-L-Cysteine / Aluminium Hydroxide / Ranitidine Hydrochloride / Albuterol Sulfate / Magnesium Trisilicate / Norfloxacin / Cimetidine / Calcium D-Pantothenate / Pyridoxine / Fusidic Acid / Acetaminophen / Phenolphthalein / Metronidazole / Nifedipine / Hydrochlorothiazide / Kasugamycin / Nystatin / Riboflavin (B2) / Gamma-Oryzanol / Tamoxifen Citrate / Cystamine Dihydrochloride / Chloro Hydrozine
Shanxi, China
Send Email
Sending...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
Mexiletine Hydrochloride
Aluminium Hydroxide
Albuterol Sulfate
S-Carboxymethyl-L-Cysteine
Calcium D-Pantothenate
Kasugamycin
Cystamine Dihydrochloride
Chloro Hydrozine
Fusidic Acid
Acetaminophen
Phenolphthalein
Nifedipine
Vitamin B2
Hydrochlorothiazide
Indometacin
Pyridoxine
Nystatin
Cimetidine
Metronidazole
Tamoxifen Citrate
Norfloxacin
Magnesium Trisilicate
Ranitidine Hydrochloride
Gamma-Oryzanol
Vitamin U
ABOUT US
Yunpeng Pharmaceutical Group is a comprehensive high-tech enterprise integrating drug R & D, production, sales and logistics. It has 200 approval numbers, 9 subsidiaries and 1 branch, with a total asset value of 1.2 billion yuan. The group has a modern production base and R & D pilot base with chemical drugs, traditional Chinese medicine and API as the core; One traditional Chinese medicine extraction production line, four R & D pilot production lines, ten oral preparation production lines, eleven chemical API production lines and injection molding production lines have passed the new version of GMP certification. The EU workshop for APIs and the EU workshop for oral preparations will be completed soon. The Group invested 100 million yuan to establish Beijing Yunpeng Pengcheng Pharmaceutical Research Institute in 2018, invested 8-10% of the profit in R & D every year, and cooperated with 6 companies such as fangtaida Co., Ltd., a famous international pharmaceutical giant. It has won the titles of "high-tech enterprise" and "high-tech innovation enterprise". The group has successively established business cooperation relations with India, Japan, the United Kingdom, South Korea and other countries, and its sales network is all over the world. At present, norfloxacin, indomethacin and mexiletine hydrochloride have been registered in India, while indomethacin has been registered in Russia, Mexico, Egypt, South Korea and other places. In Japan, mexiletine hydrochloride and vitamin U have also been reviewed by jdmf. The group has introduced advanced management concepts to build an industrialized, information-based and intelligent enterprise. At the same time, it has obtained environmental assessment certificate, safety assessment certificate, fire protection certificate, sewage discharge certificate and water intake certificate, and its strength has been comprehensively improved; And won the title of "management benchmarking enterprise in Shanxi Province" and "qualified unit for pilot work of enterprise environmental supervisor". In the future, Yunpeng people will continue to uphold the corporate mission of "contributing to the society and delivering health to the people", devote themselves to the cause of human health, and spread health and take care of life with more, newer and better health products!
Basic Information
Tax ID
911410027136140375
Country/Region
Shanxi, China
Year Established
1998
Registered Capital
CNY 200 Million
Business Type
Manufacturing
Total Employees
100-500 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
High quality generic medicine production base
PLANT LOCATION
COMPANY ALBUM
